Trinity Biotech PLC
NASDAQ:TRIB
Balance Sheet
Balance Sheet Decomposition
Trinity Biotech PLC
Current Assets | 39m |
Cash & Short-Term Investments | 3.7m |
Receivables | 15.4m |
Other Current Assets | 19.9m |
Non-Current Assets | 20.4m |
PP&E | 1.9m |
Intangibles | 16.3m |
Other Non-Current Assets | 2.2m |
Current Liabilities | 15m |
Accounts Payable | 14.5m |
Other Current Liabilities | 539k |
Non-Current Liabilities | 68.3m |
Long-Term Debt | 54.7m |
Other Non-Current Liabilities | 13.7m |
Balance Sheet
Trinity Biotech PLC
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
7
|
7
|
77
|
58
|
30
|
6
|
24
|
23
|
7
|
4
|
|
Cash |
7
|
7
|
0
|
0
|
0
|
6
|
24
|
23
|
7
|
0
|
|
Cash Equivalents |
0
|
0
|
77
|
58
|
30
|
0
|
0
|
0
|
0
|
4
|
|
Short-Term Investments |
2
|
95
|
0
|
0
|
0
|
10
|
3
|
3
|
0
|
0
|
|
Total Receivables |
26
|
21
|
24
|
22
|
26
|
22
|
25
|
16
|
16
|
15
|
|
Accounts Receivables |
20
|
20
|
23
|
21
|
24
|
20
|
21
|
14
|
14
|
14
|
|
Other Receivables |
6
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
|
Inventory |
34
|
35
|
33
|
33
|
30
|
32
|
30
|
29
|
23
|
20
|
|
Other Current Assets |
0
|
6
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
|
Total Current Assets |
69
|
163
|
134
|
113
|
87
|
71
|
83
|
73
|
47
|
39
|
|
PP&E Net |
18
|
21
|
13
|
6
|
5
|
9
|
9
|
6
|
6
|
2
|
|
PP&E Gross |
18
|
21
|
0
|
0
|
0
|
9
|
9
|
6
|
6
|
0
|
|
Accumulated Depreciation |
20
|
22
|
0
|
0
|
0
|
61
|
57
|
58
|
60
|
0
|
|
Intangible Assets |
92
|
109
|
87
|
65
|
53
|
31
|
34
|
36
|
23
|
16
|
|
Goodwill |
53
|
53
|
0
|
0
|
0
|
13
|
0
|
0
|
13
|
0
|
|
Note Receivable |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
11
|
18
|
15
|
10
|
6
|
6
|
4
|
4
|
4
|
2
|
|
Other Assets |
53
|
53
|
0
|
0
|
0
|
13
|
0
|
0
|
13
|
0
|
|
Total Assets |
243
N/A
|
364
+50%
|
250
-31%
|
193
-23%
|
151
-21%
|
131
-13%
|
130
-1%
|
119
-9%
|
92
-23%
|
59
-35%
|
|
Liabilities | |||||||||||
Accounts Payable |
10
|
8
|
25
|
21
|
17
|
8
|
10
|
7
|
6
|
14
|
|
Accrued Liabilities |
11
|
10
|
0
|
0
|
0
|
9
|
10
|
8
|
9
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
85
|
2
|
0
|
|
Other Current Liabilities |
1
|
2
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
Total Current Liabilities |
22
|
20
|
25
|
21
|
18
|
19
|
27
|
101
|
17
|
15
|
|
Long-Term Debt |
0
|
93
|
97
|
95
|
82
|
100
|
99
|
14
|
70
|
55
|
|
Deferred Income Tax |
21
|
25
|
18
|
11
|
7
|
7
|
5
|
5
|
5
|
2
|
|
Other Liabilities |
2
|
12
|
1
|
1
|
1
|
0
|
1
|
0
|
2
|
11
|
|
Total Liabilities |
46
N/A
|
150
+226%
|
141
-6%
|
127
-10%
|
107
-16%
|
126
+18%
|
133
+5%
|
119
-10%
|
94
-21%
|
83
-12%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Retained Earnings |
195
|
214
|
91
|
48
|
55
|
16
|
11
|
13
|
27
|
49
|
|
Additional Paid In Capital |
12
|
16
|
16
|
16
|
16
|
16
|
16
|
16
|
47
|
47
|
|
Treasury Stock |
7
|
7
|
0
|
0
|
29
|
25
|
25
|
25
|
25
|
25
|
|
Other Equity |
5
|
9
|
0
|
0
|
0
|
4
|
5
|
5
|
1
|
1
|
|
Total Equity |
197
N/A
|
214
+9%
|
109
-49%
|
65
-40%
|
44
-32%
|
5
-89%
|
2
N/A
|
0
+86%
|
2
-633%
|
24
-989%
|
|
Total Liabilities & Equity |
243
N/A
|
364
+50%
|
250
-31%
|
193
-23%
|
151
-21%
|
131
-13%
|
130
-1%
|
119
-9%
|
92
-23%
|
59
-35%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
92
|
96
|
96
|
96
|
96
|
96
|
96
|
96
|
165
|
31
|